-The Hindu This was informed to the High Court in a case of free treatment to a minor Delhi is the highest spender on public health in the country, the Delhi Government has claimed before the Delhi High Court. The assertion was been made by its Directorate of Health and Family Welfare during the hearing of a petition about free treatment to a minor. The government said it is spending four times on...
More »SEARCH RESULT
Total Matching Records found : 251
Funds dry up for drug discovery project -Rema Nagarajan
-The Times of India Funding for one of the foremost drug discovery projects in India came to an end on Monday as the financial year closed because the ministry of science and technology did not clear the cabinet note meant to extend funding for the project on time. The Open Source Drug Discovery (OSDD) project of the Council of Scientific and Industrial Research (CSIR), meant to discover drugs for neglected diseases, had...
More »For an all-party manifesto on health -Vinod Paul and K Srinath Reddy
-The Hindu The entire spectrum of political leadership should take a pledge to transform the healthcare system of India in a decade As the countdown to the next general election begins, political parties are making multiple promises to pull in votes. All the party leaders are committing to transforming the lives of people. But health, ironically, does not feature high on their priority list, even though it is the central pillar of...
More »Drug pricing policies bent to favour pharma industry, allege health experts -Jyotsna Singh
-Down to Earth Nearly 83 per cent medicines out of the ambit of price control policy, thus making them out of reach for most patients, say two recent reports Indicating failure of the National Pharmaceutical Pricing Policy (NPPP), 2012 and the Drugs Price Control Order (DPCO), 2013, two recently-released reports have stated that medicines are still not accessible and affordable for the citizens of the country. The reports that were jointly released...
More »Outside the patent monopolies -Ritu Kamal
-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...
More »
